- 英文名称
- Nastorazepide
- 分子式
- C29H36N4O5
- 分子量
- 520.62
- 中文别名
- (R)-3-(3-(5-环己基-1-(3,3-二甲基-2-氧代丁基)-2-氧代-2,3,4,5-四氢-1H-苯并[b][1,4]二氮杂卓-3-基)脲基)苯甲酸; (R)-(-)-3-[N′-(1-叔丁基羰基甲基-2-氧代-5-环己基-1,3,4,5-四氢-2H-1,5-苯并二氮杂卓-3-基)脲基]苯甲酸; (R)-3-(3-(5-Cyclohexyl-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepin-3-yl)ureido)benzoic acid; 3-({[(3R)-5-Cyclohexyl-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl]carbamoyl}amino)benzoic acid; 3-[[(3R)-1-cyclohexyl-5-(3,3-dimethyl-2-oxobutyl)-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]carbamoylamino]benzoic acid; Z-360; Z-360 free acid; R-(-)-Z-360 Free acid; Z360; 3-[[[[(3R)-5-Cyclohexyl-1-(3,3-dimethyl-2-oxobutyl)-2,3,4,5-tetrahydro-2-oxo-1H-1,5-benzodiazepin-3-yl]amino]carbonyl]amino]benzoic acid
- 用途
- 化学合成;作为选择性口服有效的1,5-苯并二氮杂环衍生物胃泌素/胆囊收缩素2(CCK-2)受体拮抗剂,具有潜在抗肿瘤活性。